BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33530261)

  • 21. Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019.
    Yu M; Wang DC; Li S; Lei YH; Wei J; Huang LY
    J Med Virol; 2022 Apr; 94(4):1513-1522. PubMed ID: 34837230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.
    Vankadari N
    Int J Antimicrob Agents; 2020 Aug; 56(2):105998. PubMed ID: 32360231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19: A Retrospective Matched Case-Control Study.
    Zhang HT; Huang MX; Liu X; Zheng XC; Li XH; Chen GQ; Xia JY; Hong ZS
    Am J Chin Med; 2020; 48(4):779-792. PubMed ID: 32420751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effect of Arbidol in the management of COVID-19 infection.
    Jie X; Hongmei Y; Ping F; Kuikui Z; Bohan Y; Rui M
    Aging (Albany NY); 2021 Apr; 13(7):9253-9264. PubMed ID: 33811756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quadruple therapy for asymptomatic COVID-19 infection patients.
    Wang L; Xu X; Ruan J; Lin S; Jiang J; Ye H
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):617-624. PubMed ID: 32362193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xuebijing injection in the treatment of COVID-19: a retrospective case-control study.
    Guo H; Zheng J; Huang G; Xiang Y; Lang C; Li B; Huang D; Sun Q; Luo Y; Zhang Y; Huang L; Fang W; Zheng Y; Wan S
    Ann Palliat Med; 2020 Sep; 9(5):3235-3248. PubMed ID: 32954754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission: A Preliminary Report of a Retrospective Cohort Study.
    Zhang JN; Wang WJ; Peng B; Peng W; Zhang YS; Wang YL; Wan Y; Chang J; Mao L; Miao XP; Li YN; Zhou YF; Hu B
    Curr Med Sci; 2020 Jun; 40(3):480-485. PubMed ID: 32474860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A trial of arbidol hydrochloride in adults with COVID-19.
    Zhao J; Zhang J; Jin Y; Tang Z; Hu K; Sun H; Shi M; Yang Q; Gu P; Guo H; Li Q; Zhang H; Li C; Yang M; Xiong N; Dong X; Xu J; Lin F; Wang T; Yang C; Huang B; Zhang J; Chen S; He Q; Zhou M; Qu J
    Chin Med J (Engl); 2022 Jul; 135(13):1531-8. PubMed ID: 35830201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients.
    Liu Z; Li X; Gou C; Li L; Luo X; Zhang C; Zhang Y; Zhang J; Jin A; Li H; Zeng Y; Li T; Wang X
    J Tradit Chin Med; 2020 Jun; 40(3):467-472. PubMed ID: 32506862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019.
    Xia Q; Dai W; Xu K; Ni Q; Li Y; Liu J; Zhao H; Guo Y; Yu L; Yi P; Su J; Lang G; Tao J; Shi D; Wu W; Wu X; Xu Y; Xu M; Yu L; Wang X; Cai H; Fang Q; Zhou J; Qiu Y; Li L
    J Med Virol; 2021 Jul; 93(7):4446-4453. PubMed ID: 33448426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thoughts on Traditional Chinese Medicine Treatment of Novel Coronavirus Pneumonia Based on Two Cases.
    Ma J; Wu HY; Chen YZ; Huang M; Zhang LS
    Chin J Integr Med; 2021 May; 27(5):375-378. PubMed ID: 33528745
    [No Abstract]   [Full Text] [Related]  

  • 32. Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases.
    Shen P; Li J; Tu S; Wu Y; Peng Y; Chen G; Chen C
    J Ethnopharmacol; 2021 Oct; 278():114220. PubMed ID: 34029640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis.
    Amani B; Amani B; Zareei S; Zareei M
    Immun Inflamm Dis; 2021 Dec; 9(4):1197-1208. PubMed ID: 34347937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals.
    Yang C; Ke C; Yue D; Li W; Hu Z; Liu W; Hu S; Wang S; Liu J
    Front Public Health; 2020; 8():249. PubMed ID: 32574310
    [No Abstract]   [Full Text] [Related]  

  • 35. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
    Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Traditional Chinese Medicine as Potential Therapy for COVID-19.
    Li S; Liu C; Guo F; Taleb SJ; Tong M; Shang D
    Am J Chin Med; 2020; 48(6):1263-1277. PubMed ID: 32907358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19).
    Shi J; Lu Y; Zhang Y; Xia L; Ye C; Lü Y; Chen S; Xu Q; Tang B; Yin K; Zhang J; Chen X; Yang Z
    Am J Chin Med; 2020; 48(7):1523-1538. PubMed ID: 33148005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.